Gutmann DH - Search Results

1

Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.

Ding H, Shannon P, Lau N, Wu X, Roncari L, Baldwin RL, Takebayashi H, Nagy A, Gutmann DH, Guha A. Ding H, et al. Among authors: gutmann dh. Cancer Res. 2003 Mar 1;63(5):1106-13. Cancer Res. 2003. PMID: 12615729

2

Acute presentation of a neurogenic sarcoma in a patient with neurofibromatosis type 1: a pathological and molecular explanation. Case report.

Feldkamp MM, Lau N, Provias JP, Gutmann DH, Guha A. Feldkamp MM, et al. Among authors: gutmann dh. J Neurosurg. 1996 May;84(5):867-73. doi: 10.3171/jns.1996.84.5.0867. J Neurosurg. 1996. PMID: 8622163

3

Ras-GTP levels are elevated in human NF1 peripheral nerve tumors.

Guha A, Lau N, Huvar I, Gutmann D, Provias J, Pawson T, Boss G. Guha A, et al. Oncogene. 1996 Feb 1;12(3):507-13. Oncogene. 1996. PMID: 8637706

4

Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras.

Gutmann DH, Giordano MJ, Mahadeo DK, Lau N, Silbergeld D, Guha A. Gutmann DH, et al. Oncogene. 1996 May 16;12(10):2121-7. Oncogene. 1996. PMID: 8668337

5

Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas.

Wienecke R, Guha A, Maize JC Jr, Heideman RL, DeClue JE, Gutmann DH. Wienecke R, et al. Among authors: gutmann dh. Ann Neurol. 1997 Aug;42(2):230-5. doi: 10.1002/ana.410420215. Ann Neurol. 1997. PMID: 9266734

6

Neurofibromatosis type 1: piecing the puzzle together.

Feldkamp MM, Gutmann DH, Guha A. Feldkamp MM, et al. Among authors: gutmann dh. Can J Neurol Sci. 1998 Aug;25(3):181-91. doi: 10.1017/s0317167100033990. Can J Neurol Sci. 1998. PMID: 9706718 Review.

7

Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.

Lau N, Feldkamp MM, Roncari L, Loehr AH, Shannon P, Gutmann DH, Guha A. Lau N, et al. Among authors: gutmann dh. J Neuropathol Exp Neurol. 2000 Sep;59(9):759-67. doi: 10.1093/jnen/59.9.759. J Neuropathol Exp Neurol. 2000. PMID: 11005256

8

Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.

Ding H, Roncari L, Shannon P, Wu X, Lau N, Karaskova J, Gutmann DH, Squire JA, Nagy A, Guha A. Ding H, et al. Among authors: gutmann dh. Cancer Res. 2001 May 1;61(9):3826-36. Cancer Res. 2001. PMID: 11325859

9

Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes.

Gutmann DH, Wu YL, Hedrick NM, Zhu Y, Guha A, Parada LF. Gutmann DH, et al. Hum Mol Genet. 2001 Dec 15;10(26):3009-16. doi: 10.1093/hmg/10.26.3009. Hum Mol Genet. 2001. PMID: 11751683

10

Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo.

Huang ZY, Baldwin RL, Hedrick NM, Gutmann DH. Huang ZY, et al. Among authors: gutmann dh. Oncogene. 2002 Feb 21;21(9):1325-34. doi: 10.1038/sj.onc.1205206. Oncogene. 2002. PMID: 11857076

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

569 results

Search Page

Filters